The Great Britain is witnessing a noticeable surge in interest surrounding entheogenic substances. Beyond the common use of psilocybin and LSD, researchers and adventurers are increasingly focused on less-charted areas, particularly the copyright compound and the nascent cannabinoid, CBG compound